# Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer

> **NCT00073723** · PHASE1,PHASE2 · COMPLETED · sponsor: **Celgene Corporation** · enrollment: 75 (—)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** ABI-007

## Key facts

- **NCT ID:** NCT00073723
- **Lead sponsor:** Celgene Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 75 (—)
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00073723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00073723, "Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00073723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*